comparemela.com

Global Orthopedics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

ResMed (NYSE:RMD) versus Orthofix Medical (NASDAQ:OFIX) Head-To-Head Contrast

ResMed (NYSE:RMD) versus Orthofix Medical (NASDAQ:OFIX) Head-To-Head Contrast
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Orthofix Medical (NASDAQ:OFIX) Given New $15 00 Price Target at Roth Mkm

Orthofix Medical (NASDAQ:OFIX) Given New $15 00 Price Target at Roth Mkm
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Paradigm Capital Management Inc NY Invests $3 74 Million in Orthofix Medical Inc (NASDAQ:OFIX)

Paradigm Capital Management Inc. NY bought a new stake in shares of Orthofix Medical Inc. (NASDAQ:OFIX – Free Report) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 290,500 shares of the medical device company’s stock, valued at approximately $3,736,000. Paradigm Capital […]

Paradigm Capital Management Inc NY Purchases New Position in Orthofix Medical Inc (NASDAQ:OFIX)

Paradigm Capital Management Inc. NY acquired a new stake in shares of Orthofix Medical Inc. (NASDAQ:OFIX – Free Report) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 290,500 shares of the medical device company’s stock, valued at approximately $3,736,000. A number […]

Paradigm Capital Management Inc NY Invests $3 74 Million in Orthofix Medical Inc (NASDAQ:OFIX)

Paradigm Capital Management Inc. NY bought a new stake in shares of Orthofix Medical Inc. (NASDAQ:OFIX – Free Report) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 290,500 shares of the medical device company’s stock, valued at approximately $3,736,000. Paradigm Capital […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.